Tag Archives: corporation

New way to use electric fields to deliver cancer treatment

Called iontophoresis, the technique delivers high concentrations of chemotherapy to select areas, reducing the risk of damaging healthy tissue, according to a study this week in Science Translational Medicine. “A big challenge with many drugs is getting them where they need to go,” said Lissett Bickford, an assistant professor in the Department of Biomedical Engineering and Mechanics and the Department of Mechanical Engineering, “This technology basically forces drugs directly to and through the tumor, allowing all cancer cells in the treatment zone to get that exposure.” Bickford, who now directs the Medical Devices and Drug Delivery Lab at the Institute for Critical Technology and Applied Science at Virginia Tech, participated in the study during her postdoctoral fellowship at the University of North Carolina at Chapel Hill, where she worked with lead author Joseph DeSimone, the Chancellor’s Eminent Professor of Chemistry. Chemotherapy kills cancer cells, but it’s toxic to healthy cells, too. When it’s injected into the bloodstream, only a small amount of the drug actually gets to the tumor. …

Research shows early promise of new drug for cancers caused by viruses

The research team focuses on primary effusion lymphoma (PEL), an aggressive and deadly variant of diffuse large B-cell lymphoma that frequently occurs in people infected with HIV. Though scientists have known that the Kaposi’s sarcoma-associated herpesvirus (KSHV) causes PEL, development of effective therapies has proven difficult. PEL tumors arise within body cavities and progress rapidly with an average survival of around 6 months. Combination chemotherapy represents the current standard of care for PEL, but side effects (including bone marrow suppression) and drug resistance (generated through virus-associated mechanisms) continue to limit the effectiveness of standard therapy…

Protein in blood exerts natural anti-cancer protection

The study, published June 24 online in the Proceedings of the National Academy of Sciences, suggests it may be possible to harness the power of this naturally occurring anticancer agent as a way to treat cancer, including metastases. In several different publications it has been described the ability of decorin to affect a number of biological processes including inflammatory responses, wound healing, and angiogenesis. In this new article, the study’s senior investigator, Renato Iozzo, M.D., Ph.D., has labeled decorin a "soluble tumor repressor" — the first to be found that specifically targets new blood vessels, which are pushed to grow by the cancer, and forces the vessel cells to "eat" their internal components. …